Close

Applied Genetic Technologies (AGTC) Tops Q1 EPS by 28c

Go back to Applied Genetic Technologies (AGTC) Tops Q1 EPS by 28c

Roth Capital Upgrades Applied Genetic Technologies Corp. (AGTC) to Buy

November 9, 2016 6:43 AM EST

Roth Capital upgraded Applied Genetic Technologies Corp. (NASDAQ: AGTC) from Neutral to Buy with a price target of $15.00.

For an analyst ratings summary and ratings history on Applied Genetic Technologies Corp. click... More